A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

Study Identifier
198782-003
CT.gov Identifier
NCT00464438
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Conjunctivitis
    • Study Drug
  • gatifloxacin
  • moxifloxacin 0.5% eye drops
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    N/A - 31 Days
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * diagnosed with bacterial conjunctivitis
    Exclusion Criteria:
    * chemical or foreign body trauma to either eye * infection in either eye (besides bacterial conjunctivitis) * white spots in the cornea or ulcers in either eye * clinical diagnosis of chlamydia or gonorrhea in either eye

    Protocol Summary

    This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age

    Study Locations

    Location
    Status
    Location
    Sacramento, California, United States
    Status
    Not applicable
    Location
    Whitby, Ontario, Canada
    Status
    Not applicable